company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,41247.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,41247.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,261.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,81160.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-824535.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,289135.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-412732.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-412732.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-83333.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-83333.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-83333.0
TG Therapeutics Inc,TGTX,,0001001316,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-496065.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30115.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30115.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-30115.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30115.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,30115.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,30115.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,30115.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-561956.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-561956.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,86494.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,419000.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-56462.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-56462.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,10386.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10386.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10386.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9794567.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9794567.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9794567.0
TG Therapeutics Inc,TGTX,,0001001316,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9748491.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17396538.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17396538.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16766509.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-231605.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-861634.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-861634.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-200000.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-20416.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,12257309.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12036893.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12036893.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q1,2012-01-01,2012-03-31,2013-05-14 16:30:57+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11175259.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2574159.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2574159.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,902394.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1171980.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-499785.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-499785.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1399.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1399.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1399.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-55487.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-55487.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-55487.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-556671.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2710201.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2710201.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,118.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,803390.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1086520.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2993213.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2993213.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2993213.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3502054.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3502054.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,117.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1816890.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,851715.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-833332.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-833332.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-84538.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-84539.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-84539.0
TG Therapeutics Inc,TGTX,,0001001316,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-917871.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3673611.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3673611.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,115.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1830639.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-361891.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2204748.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2204748.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuinginvestingactivities,acquisitions,Acquisitions,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,936920.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,936920.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,936920.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q1,2013-01-01,2013-03-31,2014-05-14 16:30:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1267828.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6584552.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6584552.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,194.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1314324.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2713675.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2556359.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2556359.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1672.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1672.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1672.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,786816.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,786816.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,786816.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1771215.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4556195.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4556195.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,325.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,900985.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2500915.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1153970.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1153970.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1627.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1627.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1627.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,37922042.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,37922042.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,37922042.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36766445.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5663852.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5663852.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,493.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,975.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1540231.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-701880.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4824033.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4824033.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2382.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4919871.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4922253.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4922253.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-85121.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-149799.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,283275.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,48355.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,48355.0
TG Therapeutics Inc,TGTX,,0001001316,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9697931.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7547249.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7547249.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,706.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,15255.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4187036.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4984639.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8328891.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8328891.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3165.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-3165.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-3165.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-677778.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,18120695.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17442917.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17442917.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:35:27+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9110861.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11986430.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11986430.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,852.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,51688.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8993756.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-632981.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3573115.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3573115.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9218008.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9218008.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9218008.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,272773.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,272773.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,272773.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12518350.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17451169.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17451169.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,896.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,60317.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8259346.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1079635.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8050975.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8050975.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1333.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1333.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1333.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,24200130.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,24200130.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,24200130.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16147822.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18796429.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18796429.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1477.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,66321.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4555470.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-933777.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15106938.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15106938.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14072.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9118711.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9132783.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9132783.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-51980.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,26779686.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,26727706.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,26727706.0
TG Therapeutics Inc,TGTX,,0001001316,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2487985.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14577735.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14577735.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2419.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,80597.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5352984.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,259382.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8882353.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8882353.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6883.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3850000.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3843117.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3843117.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,19438.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,35349335.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,35329897.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,35329897.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 16:31:51+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,30290661.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17103183.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17103183.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3386.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,124812.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6265102.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1538643.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12248526.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12248526.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20280.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35070625.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-6883.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4000000.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-31084022.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-31084022.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,17628188.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,17628189.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,17628189.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-25704359.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13655916.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13655916.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,4521.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,172361.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1125326.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1694976.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10658732.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10658732.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-38914.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5884512.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6000000.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,76574.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,76574.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,15744012.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15744012.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5161854.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17611812.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17611812.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,5126.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,158372.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2892832.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1654821.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12900661.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12900661.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,16977.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8038515.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10500000.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2478462.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2478462.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,21588.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,21588.0
TG Therapeutics Inc,TGTX,,0001001316,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-10400611.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13848662.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13848662.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,6380.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,128329.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1639325.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4598913.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16673541.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16673541.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-282261.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-10641270.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9000000.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1923531.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1923531.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-8000.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,22163.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14163.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14163.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:16:54+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18582909.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15899062.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15899062.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,16939.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,125803.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1615635.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1290164.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-12850521.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-12850521.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-27795.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4558652.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6000000.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1413553.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1413553.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,8000.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,3989.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3532369.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3536380.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3536380.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7900588.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24831027.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24831027.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,19145.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,113541.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2826535.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6829605.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15042201.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15042201.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-12959.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15589219.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15576260.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15576260.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,44630.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,44630.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,578689.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23674249.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23674249.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20536.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,91327.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-756495.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7298144.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17020737.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17020737.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20985.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-78.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11499781.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11478718.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11478718.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-3016.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1423843.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1420827.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1420827.0
TG Therapeutics Inc,TGTX,,0001001316,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4121192.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27727000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27727000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,31000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6101000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-726000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22301000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22301000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6000000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6000000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6000000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,86909000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,86909000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,86909000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 16:01:19+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,70608000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28354000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28354000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,14000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1468000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,22000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26829000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26829000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4998000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4998000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3796000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3796000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3796000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18035000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31535000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31535000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,9000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4919000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3811000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22775000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22775000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8800000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8800000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8800000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,28216000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,28216000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,28216000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14241000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30860000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30860000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,132000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3516000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5337000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21855000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21855000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28006000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,-2000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-28006000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-28006000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,14738000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14738000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14738000.0
TG Therapeutics Inc,TGTX,,0001001316,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-35123000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41529000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41529000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,20000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7433000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6031000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28043000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28043000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-24000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4184000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6000000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1792000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1792000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,52430000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52430000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52430000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:01:26+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,26179000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44142000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44142000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,21000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-11000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8250000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1699000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34183000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34183000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-34000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2781000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8400000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5585000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5585000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,52023000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52023000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52023000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23425000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33951000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33951000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,56000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-292000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1155000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33009000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33009000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-26000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-17609000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11200000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-6435000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-6435000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4492000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4492000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4492000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-34952000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53860000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53860000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,24000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,88000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1315000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,18743000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33690000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33690000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-6000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6656000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6900000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,238000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,238000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,4694000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4694000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4694000.0
TG Therapeutics Inc,TGTX,,0001001316,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28758000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-35156000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-35156000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,123000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2246000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-587000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33351000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33351000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8171000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7050000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1135000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1135000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-538000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,29740000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27678000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,56880000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,56880000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 17:09:52+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22394000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-36212000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-36212000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,23000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,36000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1571000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1278000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35860000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35860000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5975000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6450000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,457000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,457000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,538000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-480000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-61000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,28287000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,28284000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,28284000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7119000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61931000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61931000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,26000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,308000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2025000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,26370000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33202000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33202000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-65000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8979000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9000000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-44000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-44000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-4000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,20699000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,20695000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,20695000.0
TG Therapeutics Inc,TGTX,,0001001316,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12551000.0
